Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diabetes DTC Ads Stand Out For Off-Label Promotion, Study Finds

Executive Summary

Drugs like Victoza, Farxiga, Jardiance, Trulicity, and Invokana were called out for promoting weight loss and blood pressure reduction by Yale University researchers in a new study published in the Journal of General Internal Medicine.

Related Content

More FDA Oversight Of DTC Ads May Be Needed To Curtail Misleading Claims, Study Argues
Rx Promotion Citations By US FDA Plummet; UCLA Webpage Elicits Final Letter Of 2017
Off-Label Communication: When Does It Align With Approved Labeling?
DTC Trouble: ‘Attention-Grabbing Visuals’ Undermine Risk Info, FDA Tells Celgene, Sanofi
DTC Advertising Is Back With A Bang


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts